☆ 4.4 Review

Safety Considerations for Use of Bone-Targeted Agents in Patients With Cancer

SEMINARS IN ONCOLOGY (2010)

Get Full Text
Add to Collection

Journal

SEMINARS IN ONCOLOGY
Volume 37, Issue 3, Pages S66-S72

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.seminoncol.2010.06.006

Keywords

-

Categories

Oncology

Funding

  1. Merck Co., Inc.
  2. Novartis Pharmaceuticals Corporation

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.